Gautam Sanyal

Title: Gautam Sanyal: Innovator in Pharmaceutical Formulations

Introduction

Gautam Sanyal is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stabilized human papillomavirus (HPV) formulations. With a total of 2 patents, Sanyal's work is recognized for its innovative approach to enhancing the stability and efficacy of medical treatments.

Latest Patents

Sanyal's latest patents include formulations that prevent protein aggregation and maintain prolonged stability as aqueous solutions. One of his key inventions is a stabilized human papillomavirus formulation that incorporates a salt, such as sodium chloride, and a non-ionic surfactant, Polysorbate 80 (Tween 80®), in physiologically acceptable concentrations. Another significant patent is a controlled-pH formulation designed for intravesicular instillation, which provides a buffered pharmaceutical dosage system for delivering TGF.alpha.PE.sub.40 ab to the human bladder for chemotherapy in bladder cancer. This formulation maintains a pH range that maximizes the interaction of the therapeutic agent with cancer cells while preventing aggregation.

Career Highlights

Gautam Sanyal is currently employed at Merck & Co., Inc., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing effective treatments that address critical health issues.

Collaborations

Sanyal has collaborated with esteemed colleagues, including Li Shi and Dorothy Marquis-Omer, to further enhance the impact of his research and innovations in the pharmaceutical field.

Conclusion

Gautam Sanyal's contributions to pharmaceutical formulations demonstrate his commitment to improving medical treatments through innovation. His patents reflect a deep understanding of the complexities involved in drug formulation and stability.